Globus Medical (NYSE:GMED) shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast.
Wells Fargo analyst Vik Chopra lowered the firm’s price target on Globus Medical (GMED) to $93 from $95 and keeps an Overweight rating on the ...
BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical (GMED) to $94 from $91 and keeps a Buy rating on the shares after ...
Zacks.com on MSN21h
Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock DipsGlobus Medical, Inc. GMED reported fourth-quarter 2024 adjusted earnings per share (EPS) of 84 cents, which beat the Zacks ...
Portman Ridge Finance Corporation (NASDAQ: PTMN ) Click to Take Action Portman Ridge Finance Corporation has agreed to be acquired by Logan Ridge Finance Corporation. Under the proposed agreement, ...
MyChesCo on MSN3h
Globus Medical Reports Record Sales and Strong Growth in 2024Globus Medical, Inc. (NYSE: GMED) posted record financial results for both the fourth quarter and full year of 2024, ...
Globus Medical saw a strong 2024 with multiple new product launches and more innovation is on the way, President and CEO Dan Scavilla said in a Feb. 20 earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback